Factors Affecting Adverse Effects Of Methotrexate In Juvenile Idiopathic Arthritis
Journal of Clinical Pediatrics · 16.06.2026 · 17 (1)
DOI: 10.52338/jocp.2026.5782 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Pediatrics, online erschienen am 16.06.2026. Verfasst von Hanan Abushwereb und 2 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Juvenile idiopathic arthritis (JIA) is treated with methotrexate (MTX), but its adverse effects can lead to treatment discontinuation. This study investigates the incidence and risk factors of MTX side effects in JIA patients.
Methods
A retrospective study of 123 JIA patients (aged 1-18 years) treated with MTX between 2002 and 2020 was conducted.
Results
78.9% of patients experienced MTX side effects. Younger patients (
Zitieren
APA
Abushwereb, H., Ertimi, F., & Hashad, S. (2026). Factors Affecting Adverse Effects Of Methotrexate In Juvenile Idiopathic Arthritis. Journal of Clinical Pediatrics, 17(1). https://doi.org/10.52338/jocp.2026.5782
Vancouver
Abushwereb H, Ertimi F, Hashad S. Factors Affecting Adverse Effects Of Methotrexate In Juvenile Idiopathic Arthritis. Journal of Clinical Pediatrics. 2026;17(1). doi:10.52338/jocp.2026.5782
BibTeX
@article{Abushwereb2026,
author = {Abushwereb, Hanan and Ertimi, Fatma and Hashad, Souad},
title = {Factors Affecting Adverse Effects Of Methotrexate In Juvenile Idiopathic Arthritis},
journal = {Journal of Clinical Pediatrics},
year = {2026},
volume = {17},
number = {1},
doi = {10.52338/jocp.2026.5782}
}
EUVIMED